Oct 28, 2016
Research by Dr. Edward Gunther, professor of medicine, Penn State Cancer Institute, and others shows how communication between genetically distinct subclones contributes to tumor growth in Wnt-driven mammary cancers, a widely used murine breast cancer model.
Gynecological oncologist Dr. Rebecca Phaëton and Nadine Hempel, PhD, associate professor, pharmacology, at Penn State Cancer Institute, started a gynecologic malignancies working group to enhance interactions between clinical and basic researchers.
Oct 8, 2016
Penn State Health Milton S. Hershey Medical Center is an investigational site for clinical development of several new immunotherapies that may help patients with aggressive, high-grade malignant brain cancers such as glioblastoma multiforme and anaplastic astrocytoma.
Partnered with regional hospitals, Penn State Health Milton S. Hershey Medical Center’s TeleStroke program has continually improved door-to-needle time for administration of intravenous tissue plasminogen activator in patients with suspected acute ischemic stroke.
This Penn State Children’s Hospital program combines medical management, nursing case management, community outreach and education to better manage the complex medical needs of children with serious neurological diagnoses and to reduce the burden on families.
Sep 27, 2016
Penn State Health Milton S. Hershey Medical Center has addressed the challenge of an aging population, an increase in the number of ICU beds and the demand for intensivists, with intensivist-led care teams that increasingly rely on nurse practitioners (NPs), while continuing to meet the complex needs of critically ill patients.
Two-thirds of primary liver cancer patients and 90 percent of secondary liver cancer patients have inoperable tumors that are unresponsive to systemic chemotherapy and may benefit from transarterial chemoembolization or radioembolization with yttrium-90 (Y-90), both minimally-invasive, palliative procedures.
By the year 2050, it is estimated that nearly 16 million people could suffer from atrial fibrillation (AF), but not all will tolerate long-term anticoagulant therapy. The WATCHMAN™ Left Atrial Appendage Closure (LAAC) device, the latest minimally invasive option at the Heart and Vascular Institute, can help bridge this clinical gap.
Penn State Health Milton S. Hershey Medical Center has joined two multicenter trials that evaluate a total artificial heart (TAH) and may save the lives of even more patients with irreversible biventricular heart failure (BVHF).
Aug 14, 2016
Patellar instability, with repeated lateral dislocation, commonly seen in younger, active adults, is associated with a number of anatomical pathologies and usually requires surgical intervention. Among these, increased tibial tubercle to trochlear groove (TT-TG) distance is a prominent risk factor. TT-TG distance describes the degree of lateralization of the tibial tubercle.
